Purchase Order 75N95C24P00010
- Not listed
- This federal contract task order was awarded by the U.S. Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $1,376,049.53 cost-plus-fixed-fee task order, awarded on August 15, 2018, supports the Medicinal Chemistry Support Program for Therapeutic Development, providing chemistry, manufacturing, and controls...
- This federal contract award is for Task C03 under the Nonclinical Services for Development of Interventional Agents contract, a delivery order awarded to Curia Global Inc., doing business as Amri. Amri is a leading contract development and manufacturing organization (CDMO) that provides a wide range of pharmaceutical research and development services to federal agencies, particularly the National Institutes of Health (NIH) and its institutes. The award has a total ceiling value of $860,162.70...
- This is a delivery order awarded to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $662,706.10 cost-plus-fixed-fee contract is to provide chemistry and absorption/distribution/metabolism/excretion (ADMET) services in support of the Medicinal Chemistry Support Program (MCSP) and other NIH initiatives related to neurology, infectious diseases, and...
- This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $2,873,042.91 contract is for the Medicinal Chemistry Support Program for Therapeutic Development, under which Curia will provide a range of chemistry, manufacturing, and controls development...
- This is a delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) to Curia Global Inc., doing business as Amri, for the Medicinal Chemistry Support Program for Therapeutic Development. The contract, with a potential value of $4,042,434.33, provides chemistry, manufacturing, and controls development; exploratory chemistry; hit-to-lead chemistry; absorption/distribution/metabolism/excretion testing; process...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $3,173,498.83 cost-plus-fixed-fee Delivery Order contract to Curia Global Inc., doing business as Amri, for Exploratory Chemistry services under the Medicinal Chemistry Support Program for Therapeutic Development. The contract has a completion date of February 1, 2026 and does not have a small business set-aside designation. Curia, a global contract...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke (HHS-NIH-NINDS) awarded a $2.77 million delivery order to Curia Global Inc., doing business as Amri, under an indefinite-delivery/indefinite-quantity contract for Hit to Lead Chemistry under Performance Area 2. The delivery order is for Medicinal Chemistry Support Program for Therapeutic Development services to be performed in Albany, New York over a three year period...
- This $142,500 firm-fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a global contract development and manufacturing organization (CDMO). The contract is for sequencing services to identify molecules that bind the KIAA0203 protein, in support of the NIH's preclinical drug discovery efforts. No set-aside designation was used. Curia has provided...
- This is a delivery order contract awarded by the National Institute of Mental Health (NIMH) to Curia Global Inc., doing business as Amri, a leading contract development and manufacturing organization (CDMO). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and is for exploratory chemistry research related to Alzheimer's disease. The contract has a ceiling value of $607,397.30 and a performance period ending on June 2, 2025. The contract is a...
- Curia Global Inc., doing business as Amri, has been awarded a $620,125 delivery order against the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases' Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity contract. The delivery order is for scale-up synthesis of APX2039, a novel GWT1 enzyme inhibitor in fungi, in support of NIH's efforts to develop new treatments for...
Curia Global Inc., doing business as Amri, has been awarded an $11,250 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to provide purification services for McHenry-CNA35 (4L). As a leading global contract development and manufacturing organization, Amri will utilize its expertise in medicinal chemistry, chemical development, analytical testing, formulation development, and cGMP manufacturing to deliver the requested products. This award was issued directly rather than through an indefinite-delivery/indefinite-quantity contract vehicle. No set-aside designation was specified. Amri will leverage its experience supporting therapeutic initiatives in areas such as Alzheimer's disease, Parkinson's disease, pain, stroke, substance abuse, and infectious diseases through contracts with various NIH institutes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 2/7/24 |